• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚焦 NLRX1 的细胞类型特异性调控作用。

Focusing on the Cell Type Specific Regulatory Actions of NLRX1.

机构信息

Department of Immunology, Faculty of Medicine, University of Debrecen, 1 Egyetem Square, H-4032 Debrecen, Hungary.

Doctoral School of Molecular Cell and Immune Biology, University of Debrecen, 1 Egyetem Square, H-4032 Debrecen, Hungary.

出版信息

Int J Mol Sci. 2021 Jan 28;22(3):1316. doi: 10.3390/ijms22031316.

DOI:10.3390/ijms22031316
PMID:33525671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7865811/
Abstract

Cells utilize a diverse repertoire of cell surface and intracellular receptors to detect exogenous or endogenous danger signals and even the changes of their microenvironment. However, some cytosolic NOD-like receptors (NLR), including NLRX1, serve more functions than just being general pattern recognition receptors. The dynamic translocation between the cytosol and the mitochondria allows NLRX1 to interact with many molecules and thereby to control multiple cellular functions. As a regulatory NLR, NLRX1 fine-tunes inflammatory signaling cascades, regulates mitochondria-associated functions, and controls metabolism, autophagy and cell death. Nevertheless, literature data are inconsistent and often contradictory regarding its effects on individual cellular functions. One plausible explanation might be that the regulatory effects of NLRX1 are highly cell type specific and the features of NLRX1 mediated regulation might be determined by the unique functional activity or metabolic profile of the given cell type. Here we review the cell type specific actions of NLRX1 with a special focus on cells of the immune system. NLRX1 has already emerged as a potential therapeutic target in numerous immune-related diseases, thus we aim to highlight which regulatory properties of NLRX1 are manifested in disease-associated dominant immune cells that presumably offer promising therapeutic solutions to treat these disorders.

摘要

细胞利用多样化的细胞表面和细胞内受体来检测外源性或内源性危险信号,甚至检测其微环境的变化。然而,一些细胞质核苷酸结合寡聚化结构域样受体(NLR),包括 NLRX1,其功能不仅仅是作为一般的模式识别受体。NLRX1 在细胞质和线粒体之间的动态易位使其能够与许多分子相互作用,从而控制多种细胞功能。作为一种调节性 NLR,NLRX1 可以精细调节炎症信号级联反应、调节与线粒体相关的功能,并控制代谢、自噬和细胞死亡。然而,关于其对单个细胞功能的影响,文献数据并不一致,且常常相互矛盾。一个合理的解释可能是 NLRX1 的调节作用具有高度的细胞类型特异性,并且 NLRX1 介导的调节特征可能由特定细胞类型的独特功能活性或代谢特征决定。在这里,我们重点讨论免疫系统细胞,综述 NLRX1 的细胞类型特异性作用。NLRX1 已经成为许多与免疫相关疾病的潜在治疗靶点,因此,我们旨在强调 NLRX1 的哪些调节特性在与疾病相关的主导免疫细胞中表现出来,这些特性可能为治疗这些疾病提供有希望的治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518d/7865811/8be4ea0c2313/ijms-22-01316-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518d/7865811/b282a0b025f7/ijms-22-01316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518d/7865811/817e19e1488a/ijms-22-01316-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518d/7865811/c38ad875ed12/ijms-22-01316-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518d/7865811/e3b5bfa6f055/ijms-22-01316-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518d/7865811/4c1445e0cd40/ijms-22-01316-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518d/7865811/8be4ea0c2313/ijms-22-01316-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518d/7865811/b282a0b025f7/ijms-22-01316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518d/7865811/817e19e1488a/ijms-22-01316-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518d/7865811/c38ad875ed12/ijms-22-01316-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518d/7865811/e3b5bfa6f055/ijms-22-01316-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518d/7865811/4c1445e0cd40/ijms-22-01316-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/518d/7865811/8be4ea0c2313/ijms-22-01316-g006.jpg

相似文献

1
Focusing on the Cell Type Specific Regulatory Actions of NLRX1.聚焦 NLRX1 的细胞类型特异性调控作用。
Int J Mol Sci. 2021 Jan 28;22(3):1316. doi: 10.3390/ijms22031316.
2
NLRX1 Is a Multifaceted and Enigmatic Regulator of Immune System Function.NLRX1 是免疫系统功能的多方面和神秘调节剂。
Front Immunol. 2019 Oct 11;10:2419. doi: 10.3389/fimmu.2019.02419. eCollection 2019.
3
Underlying Mechanisms and Related Diseases Behind the Complex Regulatory Role of NOD-Like Receptor X1.NOD样受体X1复杂调控作用背后的潜在机制及相关疾病
DNA Cell Biol. 2022 May;41(5):469-478. doi: 10.1089/dna.2022.0051. Epub 2022 Mar 31.
4
NLRX1: Versatile functions of a mitochondrial NLR protein that controls mitophagy.NLRX1:一种线粒体 NLR 蛋白的多功能性,它控制着线粒体自噬。
Biomed J. 2024 Feb;47(1):100635. doi: 10.1016/j.bj.2023.100635. Epub 2023 Aug 11.
5
NLRX1 regulates TNF-α-induced mitochondria-lysosomal crosstalk to maintain the invasive and metastatic potential of breast cancer cells.NLRX1 调控 TNF-α 诱导的线粒体-溶酶体串扰以维持乳腺癌细胞的侵袭和转移能力。
Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1460-1476. doi: 10.1016/j.bbadis.2019.02.018. Epub 2019 Feb 23.
6
Behind the Scenes: Nod-Like Receptor X1 Controls Inflammation and Metabolism.幕后故事:核苷酸结合寡聚化结构域样受体X1调控炎症与代谢
Front Cell Infect Microbiol. 2020 Dec 4;10:609812. doi: 10.3389/fcimb.2020.609812. eCollection 2020.
7
The regulatory role of NLRX1 in innate immunity and human disease.NLRX1 在先天免疫和人类疾病中的调节作用。
Cytokine. 2022 Dec;160:156055. doi: 10.1016/j.cyto.2022.156055. Epub 2022 Oct 1.
8
NLRX1 Regulation Following Acute Mitochondrial Injury.NLRX1 在急性线粒体损伤后的调控。
Front Immunol. 2019 Oct 24;10:2431. doi: 10.3389/fimmu.2019.02431. eCollection 2019.
9
NLRX1 acts as tumor suppressor by regulating TNF-α induced apoptosis and metabolism in cancer cells.NLRX1通过调节肿瘤坏死因子-α(TNF-α)诱导的癌细胞凋亡和代谢发挥肿瘤抑制作用。
Biochim Biophys Acta. 2015 May;1853(5):1073-86. doi: 10.1016/j.bbamcr.2015.01.016. Epub 2015 Jan 30.
10
Modeling-Enabled Characterization of Novel NLRX1 Ligands.基于建模的新型NLRX1配体的表征
PLoS One. 2015 Dec 29;10(12):e0145420. doi: 10.1371/journal.pone.0145420. eCollection 2015.

引用本文的文献

1
Pattern Recognition by NOD-Like Receptors.NOD样受体的模式识别
Adv Exp Med Biol. 2025;1476:83-105. doi: 10.1007/978-3-031-85340-1_4.
2
The innate immune receptor NLRX1 is a novel required modulator for mPTP opening: implications for cardioprotection.先天性免疫受体NLRX1是线粒体通透性转换孔(mPTP)开放的新型必需调节因子:对心脏保护的意义。
Basic Res Cardiol. 2025 Jun 19. doi: 10.1007/s00395-025-01124-x.
3
NLRX1 mediated impaired microglial phagocytosis of NETs in cerebral ischemia and reperfusion injury.NLRX1介导脑缺血再灌注损伤中微胶质细胞对中性粒细胞胞外陷阱的吞噬功能受损。

本文引用的文献

1
NLR in eXile: Emerging roles of NLRX1 in immunity and human disease.NLRX1 在流亡中的作用:NLRX1 在免疫和人类疾病中的新作用。
Immunology. 2021 Mar;162(3):268-280. doi: 10.1111/imm.13291. Epub 2020 Dec 28.
2
NLRX1 is a key regulator of immune signaling during invasive pulmonary aspergillosis.NLRX1 是侵袭性肺曲霉病期间免疫信号转导的关键调节因子。
PLoS Pathog. 2020 Sep 21;16(9):e1008854. doi: 10.1371/journal.ppat.1008854. eCollection 2020 Sep.
3
Macrophages and the maintenance of homeostasis.巨噬细胞与内稳态的维持。
Cell Death Differ. 2025 May 21. doi: 10.1038/s41418-025-01526-3.
4
NLRX1 limits inflammatory neurodegeneration in the anterior visual pathway.NLRX1限制前视觉通路中的炎性神经变性。
J Neuroinflammation. 2025 Jan 28;22(1):21. doi: 10.1186/s12974-025-03339-0.
5
NLRX1 Inhibits LPS-Induced Microglial Death via Inducing p62-Dependent HO-1 Expression, Inhibiting MLKL and Activating PARP-1.NLRX1通过诱导p62依赖的HO-1表达、抑制混合谱系激酶结构域样蛋白(MLKL)并激活聚(ADP-核糖)聚合酶-1(PARP-1)来抑制脂多糖(LPS)诱导的小胶质细胞死亡。
Antioxidants (Basel). 2024 Apr 17;13(4):481. doi: 10.3390/antiox13040481.
6
The Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study.NLRX1 激动剂 NX-13 在活动性溃疡性结肠炎中的安全性、耐受性、药代动力学和临床疗效:一项 1b 期研究的结果。
J Crohns Colitis. 2024 May 31;18(5):762-772. doi: 10.1093/ecco-jcc/jjad192.
7
Association of NLRPs with pathogenesis of dry age-related macular degeneration.NLRP与干性年龄相关性黄斑变性发病机制的关联。
Int Ophthalmol. 2023 Dec;43(12):4869-4878. doi: 10.1007/s10792-023-02889-7. Epub 2023 Nov 8.
8
Interactions of Autophagy and the Immune System in Health and Diseases.自噬与免疫系统在健康和疾病中的相互作用。
Autophagy Rep. 2022;1(1):438-515. doi: 10.1080/27694127.2022.2119743. Epub 2022 Oct 5.
9
NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells.NLRX1在Pan02胰腺癌细胞中发挥肿瘤抑制因子的作用。
Front Oncol. 2023 Jun 5;13:1155831. doi: 10.3389/fonc.2023.1155831. eCollection 2023.
10
Bioinformatic Analysis of the Potential Common Pathogenic Mechanisms for Psoriasis and Metabolic Syndrome.基于生物信息学分析银屑病与代谢综合征的潜在共同发病机制
Inflammation. 2023 Aug;46(4):1381-1395. doi: 10.1007/s10753-023-01815-4. Epub 2023 May 24.
Cell Mol Immunol. 2021 Mar;18(3):579-587. doi: 10.1038/s41423-020-00541-3. Epub 2020 Sep 15.
4
NLRX1 knockout aggravates lipopolysaccharide (LPS)-induced heart injury and attenuates the anti-LPS cardioprotective effect of CYP2J2/11,12-EET by enhancing activation of NF-κB and NLRP3 inflammasome.NLRX1 基因敲除加剧脂多糖(LPS)诱导的心脏损伤,并通过增强 NF-κB 和 NLRP3 炎性小体的激活,减弱 CYP2J2/11,12-EET 对 LPS 的心脏保护作用。
Eur J Pharmacol. 2020 Aug 15;881:173276. doi: 10.1016/j.ejphar.2020.173276. Epub 2020 Jun 20.
5
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.一种 SARS-CoV-2 蛋白相互作用图谱揭示了药物再利用的靶标。
Nature. 2020 Jul;583(7816):459-468. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30.
6
LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis.LRR 结构域的 NLRX1 蛋白通过 dNP2 递呈抑制 T 细胞功能并缓解自身免疫性脑脊髓炎。
Theranostics. 2020 Feb 10;10(7):3138-3150. doi: 10.7150/thno.43441. eCollection 2020.
7
DJ-1 exerts anti-inflammatory effects and regulates NLRX1-TRAF6 via SHP-1 in stroke.DJ-1 通过 SHP-1 发挥抗炎作用并调节 NLRX1-TRAF6,进而对脑卒中产生影响。
J Neuroinflammation. 2020 Mar 9;17(1):81. doi: 10.1186/s12974-020-01764-x.
8
Epithelial cells: liaisons of immunity.上皮细胞:免疫联系者。
Curr Opin Immunol. 2020 Feb;62:45-53. doi: 10.1016/j.coi.2019.11.004. Epub 2019 Dec 23.
9
HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING.HPV16 通过 NLRX1 介导的 STING 降解驱动癌症免疫逃逸。
J Clin Invest. 2020 Apr 1;130(4):1635-1652. doi: 10.1172/JCI129497.
10
NLRX1 Regulation Following Acute Mitochondrial Injury.NLRX1 在急性线粒体损伤后的调控。
Front Immunol. 2019 Oct 24;10:2431. doi: 10.3389/fimmu.2019.02431. eCollection 2019.